Medicenna Therapeutics (MDNA) stock forecast for 2023. Forecast tables and graphs.

Buy or Sell AMZN stocks? (AMZN) forecasting

Amazon’s Stock Looks Cheap

February 29, 2024
Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Getting A Kredittkort Norge Approval Isn’t Difficult

February 8, 2024 Getting A Kredittkort Norge Approval Isn’t Difficult

If you meet the conditions, you can open an account for checking in Norway. However, it will be much easier and more convenient…
How to Understand Social Security: 6 Legal & Financial Tips

January 25, 2024 How to Understand Social Security: 6 Legal & Financial Tips

Understanding social security can seem overwhelming, but it’s an important part of financial planning, particularly for retirement. The following 6 legal and financial…
Finding Energy Plans with Billig Strøm Rates

January 10, 2024 Finding Energy Plans with Billig Strøm Rates

It can be overwhelming to decide on the best plan when in a state where electricity is deregulated. The number of providers is…

Medicenna Therapeutics (MDNA) stock forecast for 2023

Updated: February 25, 2024 (16:04)

Sector: Healthcare

The share price of Medicenna Therapeutics Corp. (MDNA) now

What analysts predict: $
52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Medicenna Therapeutics stocks, the 50-day moving average is the support level today.

For Medicenna Therapeutics stocks, the 200-day moving average is the support level today.

Are you interested in Medicenna Therapeutics Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Medicenna Therapeutics stock price in 2023. How much will one Medicenna Therapeutics share be worth in 2023? Is it worth taking profit / loss on MDNA stock now or waiting? What are analysts' forecasts for Medicenna Therapeutics stock?

We forecast Medicenna Therapeutics stock performance using neural networks based on historical data on MDNA stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Medicenna Therapeutics Corp. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Medicenna Therapeutics analysts is $. Today 200 Day Moving Average is the support level ( $). 50 Day Moving Average is the support level ( $).

Historical and forecast chart of Medicenna Therapeutics Corp. stock

The chart below shows the historical price of Medicenna Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the MDNA stock price can be found in the table below.

Sell or Buy Medicenna Therapeutics (MDNA) stocks? Analytic Experts Forecasting...

We present you the most up-to-date and complete review of analytical trend forecasts and views on the MDNA stock market. Experts share their opinions on what to expect.

Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. It engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.

Medicenna Therapeutics (MDNA) Forecast for 2023

Month Target Pes. Opt. Vol., %

Medicenna Therapeutics information and performance

Medicenna Therapeutics Address


Market Capitalization: N/A $

Market capitalization of the Medicenna Therapeutics Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of MDNA shares in the company outstanding by the market price of one share.


EBITDA of Medicenna Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth


Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.


Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.


EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue


The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Medicenna Therapeutics price target for 2023 by month

Related stocks from Healthcare sector


All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.